Peculiar pattern of nail pigmentation following cyclophosphamide therapy

Dermatology Online Journal

Volumn 9, Issue 3, 2003, Pages 148-151

  Dave, Shriya ^a   Thappa, Devinder M ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FEMALE; FINGER NAIL; HUMAN; NAIL PIGMENTATION; PATIENT MONITORING; PEMPHIGUS VULGARIS; REMISSION;

EID: 3042720052     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Dutz JP, Ho VC. Immunosuppressives in dermatology. An update. Dermatol Clin 1998; 16(2): 235-251.
2. Fitzpatrick JE, Yobel DE, Hood AF. Mucocutaneous complications of antineoplastic therapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Fitzpatrick's Dermatology in General Medicine, Vol.1, 5th edn., New York: McGraw Hill 1999:1642-1653.
3. Cakir B, Sucak G, Haznedar R, et al. Longitudnal pigmented nail bands during hydroxyurea therapy. Int J Dermatol 1997; 36: 236-237.
4. Manigand G. Nail pigmentation during therapy with cyclophosphamide and doxorubicin. Sem Hop 1983; 59(24): 1840-1841.
5. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367-398.
6. Srikanth M, Van Veen J, Raithatha A, et al. Cyclophosphamide-induced nail pigmentation. Br J Haematol 2002; 117: 2.
7. Baran R, Kechijian P. Longitudinal melanonychia: diagnosis and treatment. J Am Acad Dermatol 1989; 21: 1165-1175.
8. Daniel C, Scher R. Nail changes caused by systemic drugs or ingestants. Dermatol Clin 1985; 3: 491-500.
9. Aste N, Fumo G, Contu F. Nail pigmentation caused by hydroxyurea: Report of 9 cases. J Am Acad Dermatol 2002; 47: 146-147.